Progress and challenges of personalized neoantigens in the clinical treatment of tumors
Tumors are a serious threat to human health, and tumor treatments have continued to evolve from chemotherapy to targeted therapy, immunotherapy, and individualized immunotherapy. Tumor cells have many mutations that cause the production of neoantigens, which are unique to tumor cells. Tumor neoantig...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-06-01
|
| Series: | Medicine in Drug Discovery |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590098620300178 |